Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease
Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.
Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study
Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease
Objective: To study the utilization of healthcare and deep brain stimulation (DBS) in large populations of Black and White patients with Parkinson’s disease (PD). Background:…Seasonal Variations in Emergency Department Admissions Among Parkinson’s Disease Patients: A North-South Comparative Analysis
Objective: We aim to compare the effect of ambient temperature on Emergency Department (ED) admissions among Parkinson’s Disease (PD) patients in extreme and regular temperatures…Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks
Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson’s disease
Objective: In this study, we examined the prevalence of sarcopenia in patients with Parkinson's disease (PD) and the factors affecting sarcopenia in patients with PD,…Muscle Coactivation in subjects with Parkinson’s Disease: a Healthy-matched analysis of the Sub-Phases of Gait Cycle
Objective: To compare lower limb muscle coactivation (MC) during gait between Parkinson’s disease (PD) and healthy controls (HC). Background: MC increases with aging as a…Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs
Objective: To compare neuropsychiatric disorders (NPsy), other non-motor symptoms (NMS), and associated medication use and costs in individuals with advanced Parkinson’s Disease (aPD) with those…
- « Previous Page
- 1
- …
- 131
- 132
- 133
- 134
- 135
- …
- 181
- Next Page »